QURE- Uniqure N.V.

Name: Uniqure N.V. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. QURE is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kapusta Matthew C	877.8K	$21.15M	-
CFO	Klemt Christian	238.6K	$5.75M	-
Other	Abi-Saab Walid	150.4K	$3.62M	-
Other	Potts Jeannette	106.5K	$2.57M	-
Dir	Gut Robert	58.0K	$1.40M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 20, 2025	Meek David D.51	Director	Sell	2,112	$14.45	$30,518.40	-5.8%	+3.7%	-
Jun 20, 2025	Balachandran Madhavan52	Director	Sell	2,112	$14.45	$30,518.40	-5.3%	+3.7%	-
Jun 20, 2025	Gut Robert69	Director	Sell	3,336	$14.45	$48,205.20	-5.5%	+3.7%	-
Jun 20, 2025	Jacques Rachelle Suzanne53	Director	Sell	2,112	$14.45	$30,518.40	-6.9%	+3.7%	-
Jun 20, 2025	Kaye Jack53	Director	Sell	2,112	$14.45	$30,518.40	-9.4%	+3.7%	-
Jun 20, 2025	Post Leonard E47	Director	Sell	2,112	$14.45	$30,518.40	-6.6%	+3.7%	-
Jun 20, 2025	Springhorn Jeremy P.52	Director	Sell	2,112	$14.45	$30,518.40	-5.3%	+3.7%	-
Jun 16, 2025	Potts Jeannette	Chief Legal Officer	Sell	4,670	$15.14	$70,703.80	-3.9%	-1.8%	-
Mar 4, 2025	Kapusta Matthew C64	CEO, Managing Director	Sell	28,341	$10.29	$291,628.89	-4.2%	+27.8%	-20.0%
Mar 4, 2025	Abi-Saab Walid	Chief Medical Officer	Sell	1,350	$10.29	$13,891.50	-0.9%	+27.8%	-20.0%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC